SEOUL, April 1 (Yonhap) -- Samsung Biologics, the biotech arm of Samsung Group, said Wednesday it has acquired a U.S. manufacturing facility from British pharmaceutical firm GSK plc for US$280 million ...

Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics' geographical diversification and establishes its first U.S. manufacturing presence, ...

Contract development and manufacturing organization (CDMO) Samsung Biologics announced the completion of its acquisition of a GSK manufacturing site in Rockville, Maryland. The purchase will expand ...

Wearing white gloves and holding gold scissors, Korean, state and local officials cut a ribbon marking Samsung Biologics‘ first U.S.-based manufacturing facility. The South Korean company acquired the ...

OSCEOLA COUNTY, Fla. — A federal judge refused Osceola County’s request to dismiss a lawsuit by a man severely burned after being tased at a gas station. Jean Louis Barreto-Baerga filed a lawsuit ...

Good morning, everyone, and thanks for joining on day 3 of our Biopharma Innovation Summit. Very pleased to start the day this morning with a fireside chat with Kaivan Khavandi, who's Head of ...

Over the past months, GSK has been particularly active on the deal front, expanding its pipeline through multiple moves. In December alone, the company signed a string of partnerships spanning ...